Evaluation of Participant Characteristics and Short-Term Outcomes in a Community-Based Hypertension Awareness Event in Japan [0.03%]
日本社区高血压意识活动的参与者特征和短期结果评价
Noriko Taguchi,Satoshi Yanagisawa,Kyoko Tsunekawa et al.
Noriko Taguchi et al.
Percutaneous Coronary Intervention for Coronary Events during Tyrosine Kinase Inhibitor Therapy in Leukemia Patients [0.03%]
酪氨酸激酶抑制剂治疗期间白血病患者冠脉事件的经皮冠状动脉介入治疗
Asaki Saijo,Tetsuo Yamaguchi,Akinori Konishi et al.
Asaki Saijo et al.
Tyrosine kinase inhibitors (TKIs) are essential for treating chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. While cardiovascular risk with TKIs is well recognized, significant coronary artery ste...
Clinical Implications of Myocardial T1 Mapping Parameters in Relation to Left Ventricular Characteristics in Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy [0.03%]
野生型甲状腺素转运蛋白心肌病患者心肌T1图参数与左心室特征相关性的临床意义研究
Toshiro Kitagawa,Kotaro Hamamoto,Daiki Okamoto et al.
Toshiro Kitagawa et al.
Clinical Characteristics of Dynapenia and Sarcopenia in Hospitalized Patients with Cardiovascular Disease [0.03%]
心血管疾病住院患者的Dynapenia和肌少症的临床特征
Keisuke Okano,Hironori Takami,Kouki Sano et al.
Keisuke Okano et al.
Dynapenia, defined as reduced muscle strength despite preserved muscle mass, is increasingly being recognized alongside sarcopenia in older adults. Clinical differences between dynapenia and sarcopenia in hospitalized cardiovascular disease...
Relevant Adverse Events and Drug Discontinuation of Sacubitril/Valsartan in Patients with Transthyretin Amyloid Cardiomyopathy - Insights from the REVIEW-HF Registry [0.03%]
重组人转甲状腺素蛋白淀粉样变性心肌病患者的沙库巴曲缬沙坦相关不良反应及停药分析-来自REVIEW-HF注册研究的见解
Yukihiro Watanabe,Yoshiaki Kubota,Hiroshige Murata et al.
Yukihiro Watanabe et al.
Data on the safety and tolerability of sacubitril/valsartan in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are limited.The REVIEW-HF registry was a nationwide, multicenter, retrospective study that investigated the characte...
Errata: Aspirin and Celecoxib Regulate Notch1/Hes1 Pathway to Prevent Pressure Overload-Induced Myocardial Hypertrophy [0.03%]
ASA和塞来昔布通过调节Notch1/Hes1信号通路预防压力超负荷诱导的心肌肥厚补充资料
Several errors (shown with underlines) in the following list appeared in the article "Aspirin and Celecoxib Regulate Notch1/Hes1 Pathway to Prevent Pressure Overload-Induced Myocardial Hypertrophy" by Minghui Wei, Ziyu Lu, Haifeng Zhang, Xi...
Errata: Circ_0004771 Promotes Hypoxia/Reoxygenation Induced Cardiomyocyte Injury via Activation of Mitogen-Activated Protein Kinase Signaling Pathway [0.03%]
环状RNA Circ_0004771通过激活MAPK信号通路促进缺氧复氧诱导的心肌细胞损伤.erratum
An error appeared in the article entitled "Circ_0004771 Promotes Hypoxia/Reoxygenation Induced Cardiomyocyte Injury via Activation of Mitogen-Activated Protein Kinase Signaling Pathway" by Chun-jun Yu, Feng Xia, Lin Ruan, Sheng-peng Hu, Wen...
A Case of Hydrophilic Polymer Embolism after Transcatheter Aortic Valve Replacement [0.03%]
经导管主动脉瓣置换术后水溶性聚合物栓塞1例
Yuya Kobayashi,Satoshi Kawaguchi,Yuya Kitani et al.
Yuya Kobayashi et al.
Recently, endovascular catheter-based interventions have become an established therapeutic option for severe valvular heart disease. Although cholesterol crystal embolism is a well-recognized complication of endovascular treatment, the hydr...
Case Reports
International heart journal. 2026;67(2):186-190. DOI:10.1536/ihj.25-564 2026
Association between Periaortic Adipose Tissue on Computed Tomography and Aortic Vulnerable Plaques Evaluated by Non-Obstructive General Angioscopy [0.03%]
基于非狭窄性血管内镜观察的升主动脉易损斑块与腹主动脉周围脂肪组织CT值的相关性研究
Yutaka Koyama,Keisuke Kojima,Yuta Hotsubo et al.
Yutaka Koyama et al.
Periaortic adipose tissue (PAAT) is known to promote atherosclerosis and has been linked to cardiovascular disease (CVD). However, its association with aortic plaque instability remains unclear. This study aimed to assess whether PAAT is as...